Pembrolizumab plus belzutifan combination shows promise as an adjuvant treatment for kidney cancer
A large phase 3 clinical trial tested two medicines, pembrolizumab [...]
Comparison of real-world outcomes from combination therapies for advanced kidney cancer
Direct comparisons of combination treatments for previously untreated, advanced kidney [...]
Pembrolizumab plus axitinib shows sustained benefit in advanced kidney cancer
The final long-term follow-up data from the phase 3 KEYNOTE-426 [...]
Pembrolizumab-axitinib versus nivolumab-cabozantinib as first-line treatment for metastatic kidney cancer
Treatment of advanced (metastatic) kidney cancer has improved considerably over [...]
Combinations of pembrolizumab and targeted therapies for advanced clear cell kidney cancer
The KEYMAKER-U03 study is looking at different combinations of immunotherapy [...]
New treatment for pretreated advanced kidney cancer shows promise
A new treatment, called NDI-101150 has been shown to be [...]
New cancer vaccine in development
A new vaccine is being heralded as a 'game changer’ [...]
Adjuvant pembrolizumab prolongs overall survival for kidney cancer patients
Surgery (partial or radical nephrectomy) is the standard of care [...]
Lenvatinib plus pembrolizumab for advanced kidney cancer
The final survival information from the phase 3 CLEAR study [...]
Patient’s perspective on pembrolizumab/lenvatinib for kidney cancer
In 2009, Cesar Fuentes was first diagnosed with kidney cancer [...]
